ATE329032T1 - Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff - Google Patents
Haemophilus influenza äusseres membranprotein und verwendung davon als impstoffInfo
- Publication number
- ATE329032T1 ATE329032T1 AT01913816T AT01913816T ATE329032T1 AT E329032 T1 ATE329032 T1 AT E329032T1 AT 01913816 T AT01913816 T AT 01913816T AT 01913816 T AT01913816 T AT 01913816T AT E329032 T1 ATE329032 T1 AT E329032T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccine
- membrane protein
- haemophilus influenza
- external membrane
- relates
- Prior art date
Links
- 241000606768 Haemophilus influenzae Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 108010052285 Membrane Proteins Proteins 0.000 title 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 2
- 108010071023 Bacterial Outer Membrane Proteins Proteins 0.000 abstract 1
- 206010061190 Haemophilus infection Diseases 0.000 abstract 1
- 101710105759 Major outer membrane porin Proteins 0.000 abstract 1
- 101710164702 Major outer membrane protein Proteins 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0003502.2A GB0003502D0 (en) | 2000-02-15 | 2000-02-15 | Vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE329032T1 true ATE329032T1 (de) | 2006-06-15 |
Family
ID=9885665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01913816T ATE329032T1 (de) | 2000-02-15 | 2001-02-13 | Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20030096370A1 (de) |
| EP (1) | EP1254234B1 (de) |
| JP (1) | JP4815090B2 (de) |
| AT (1) | ATE329032T1 (de) |
| AU (1) | AU2001239262A1 (de) |
| CA (1) | CA2399480C (de) |
| DE (1) | DE60120357T2 (de) |
| ES (1) | ES2264438T3 (de) |
| GB (1) | GB0003502D0 (de) |
| WO (1) | WO2001061013A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9812613D0 (en) * | 1998-06-11 | 1998-08-12 | Smithkline Beecham Biolog | Vaccine |
| EA014352B1 (ru) | 2005-08-10 | 2010-10-29 | Арне Форсгрен Аб | Взаимодействие moraxella catarrhalis с эпителиальными клетками, внеклеточными матриксными белками и системой комплемента |
| EP1973933B1 (de) | 2006-01-17 | 2020-06-24 | Forsgren, Arne | Neues oberflächenexponiertes haemophilus influenzae-protein (protein e; pe) |
| US8617574B2 (en) | 2009-02-13 | 2013-12-31 | Valneva Austria Gmbh | Nontypable Haemophilus influenzae antigens |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9812613D0 (en) * | 1998-06-11 | 1998-08-12 | Smithkline Beecham Biolog | Vaccine |
-
2000
- 2000-02-15 GB GBGB0003502.2A patent/GB0003502D0/en not_active Ceased
-
2001
- 2001-02-13 CA CA2399480A patent/CA2399480C/en not_active Expired - Fee Related
- 2001-02-13 US US10/203,942 patent/US20030096370A1/en not_active Abandoned
- 2001-02-13 WO PCT/EP2001/001556 patent/WO2001061013A1/en active IP Right Grant
- 2001-02-13 EP EP01913816A patent/EP1254234B1/de not_active Expired - Lifetime
- 2001-02-13 DE DE60120357T patent/DE60120357T2/de not_active Expired - Lifetime
- 2001-02-13 JP JP2001559850A patent/JP4815090B2/ja not_active Expired - Fee Related
- 2001-02-13 AU AU2001239262A patent/AU2001239262A1/en not_active Abandoned
- 2001-02-13 AT AT01913816T patent/ATE329032T1/de not_active IP Right Cessation
- 2001-02-13 ES ES01913816T patent/ES2264438T3/es not_active Expired - Lifetime
-
2006
- 2006-01-20 US US11/336,327 patent/US20060251671A1/en not_active Abandoned
-
2007
- 2007-12-20 US US11/960,883 patent/US7811590B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2399480C (en) | 2011-11-15 |
| JP2003522543A (ja) | 2003-07-29 |
| DE60120357T2 (de) | 2007-06-06 |
| CA2399480A1 (en) | 2001-08-23 |
| GB0003502D0 (en) | 2000-04-05 |
| WO2001061013A1 (en) | 2001-08-23 |
| US20060251671A1 (en) | 2006-11-09 |
| AU2001239262A1 (en) | 2001-08-27 |
| ES2264438T3 (es) | 2007-01-01 |
| US7811590B2 (en) | 2010-10-12 |
| EP1254234A1 (de) | 2002-11-06 |
| JP4815090B2 (ja) | 2011-11-16 |
| DE60120357D1 (de) | 2006-07-20 |
| US20030096370A1 (en) | 2003-05-22 |
| US20090175912A1 (en) | 2009-07-09 |
| EP1254234B1 (de) | 2006-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2001002199A0 (en) | Novel streptococcus antigens | |
| MXPA03000103A (es) | Antigenos de streptococcus. | |
| DK1093517T3 (da) | Neisseria-meningitidis-antigener og præparater | |
| DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
| ATE277081T1 (de) | Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten | |
| HUP0302965A2 (hu) | Vakcina | |
| CY1106806T1 (el) | Dna και πολυπεπτιδια ανθρωπινης tslp | |
| BR0010720A (pt) | Peptìdeos de neisseria antigênicos | |
| AP2000001886A0 (en) | Group B streptococcus antigens. | |
| DE69829668D1 (de) | Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe | |
| ATE337399T1 (de) | Zusammensetzungen zur immuntherapie und diagnose von tuberculosis | |
| WO2004006952A3 (en) | Therapeutic tuberculosis vaccines | |
| DE60039050D1 (de) | Antigene meningokokken peptide | |
| DE50112802D1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| NZ500540A (en) | Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae | |
| DK1007685T3 (da) | Overfladeeksponerede proteiner fra chlamydia pneumoniae | |
| DE60118359D1 (de) | Humanische pellino-polypeptide | |
| EP1214088A4 (de) | Durch mycobacterium tuberculosis und nicht durch bcg exprimierte proteine und ihre verwendung als diagnostische reagenzien und impfstoffe | |
| EP1613345A4 (de) | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 | |
| ATE329032T1 (de) | Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff | |
| DK0680765T3 (da) | Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme | |
| NZ335633A (en) | Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases | |
| ATE550345T1 (de) | Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren | |
| NO20005081D0 (no) | Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav | |
| ATE281524T1 (de) | Moraxella catarrhalis pilq proteine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |